[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insmed Inc (INSM)

Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,644,080
  • Shares Outstanding, K 216,752
  • Annual Sales, $ 606,420 K
  • Annual Income, $ -1,277 M
  • EBIT $ -1,145 M
  • EBITDA $ -1,120 M
  • 60-Month Beta 0.79
  • Price/Sales 36.98
  • Price/Cash Flow N/A
  • Price/Book 31.68

Options Overview Details

View History
  • Implied Volatility 62.37% (+4.09%)
  • Historical Volatility 53.42%
  • IV Percentile 91%
  • IV Rank 51.62%
  • IV High 89.51% on 12/17/25
  • IV Low 33.42% on 09/11/25
  • Expected Move (DTE 20) 7.96 (7.70%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 2,361
  • Volume Avg (30-Day) 2,805
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 102,975
  • Open Int (30-Day) 101,124
  • Expected Range 95.42 to 111.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.75
  • Number of Estimates 9
  • High Estimate $-0.59
  • Low Estimate $-1.06
  • Prior Year $-1.70
  • Growth Rate Est. (year over year) +55.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.39 +14.37%
on 06/10/26
109.95 -5.98%
on 05/28/26
-5.49 (-5.04%)
since 05/26/26
3-Month
90.39 +14.37%
on 06/10/26
166.18 -37.79%
on 04/06/26
-44.22 (-29.96%)
since 03/26/26
52-Week
90.39 +14.37%
on 06/10/26
212.75 -51.41%
on 12/02/25
+1.64 (+1.61%)
since 06/26/25

Most Recent Stories

More News
Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

BRIDGEWATER, N.J. , June 23, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform...

INSM : 103.38 (-1.04%)
Incyte Stock: Is INCY Outperforming the Healthcare Sector?

Incyte has rallied the healthcare sector over the past year, and analysts remain moderately optimistic about its prospects.

XLV : 160.34 (+3.03%)
INCY : 113.75 (+5.78%)
INSM : 103.38 (-1.04%)
Dear CoreWeave Stock Fans, Mark Your Calendars for June 22

CoreWeave stock has been included in the illustrious Nasdaq 100 club starting June 22.

TER : 436.86 (-7.44%)
NVDA : 192.53 (-1.64%)
META : 550.25 (+1.36%)
^ETHUSD : 1,576.180 (+0.51%)
$NASX : 25,297.62 (-0.24%)
RKLB : 84.54 (+4.77%)
MSFT : 372.97 (+5.71%)
CRWV : 96.58 (-2.21%)
ALAB : 391.74 (-1.57%)
CTSH : 40.03 (+2.25%)
ZS : 132.26 (+6.83%)
NBIS : 240.30 (-6.36%)
Stocks Rally on Hopes for a Near-term US-Iran Interim Peace Agreement

The S&P 500 Index ($SPX ) (SPY ) on Friday rose +0.50%, the Dow Jones Industrial Average ($DOWI ) (DIA ) rose +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.64%. June E-mini S&P futures (ESM26...

TER : 436.86 (-7.44%)
UAL : 136.11 (+1.12%)
SNDK : 2,090.71 (-10.46%)
RKLB : 84.54 (+4.77%)
$IUXX : 29,118.24 (-1.09%)
ZNU26 : 110-085s (+0.16%)
CRWV : 96.58 (-2.21%)
ALAB : 391.74 (-1.57%)
ESU26 : 7,401.75s (-0.29%)
QCOM : 189.39 (-7.57%)
AMD : 521.58 (-2.06%)
CTSH : 40.03 (+2.25%)
Stocks See Support from Hopes for a Near-term US-Iran Peace Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.58%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.64%. June E-mini S&P futures (ESM26 ) are...

TER : 436.86 (-7.44%)
UAL : 136.11 (+1.12%)
MPC : 254.06 (+0.20%)
SNDK : 2,090.71 (-10.46%)
INTU : 267.72 (+4.96%)
RKLB : 84.54 (+4.77%)
$IUXX : 29,118.24 (-1.09%)
ZNU26 : 110-085s (+0.16%)
OXY : 49.99 (-2.38%)
CRWV : 96.58 (-2.21%)
ALAB : 391.74 (-1.57%)
ESU26 : 7,401.75s (-0.29%)
Stocks See Support from Hopes for a Near-term US-Iran Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.29%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.41%. June E-mini S&P futures (ESM26 ) are...

UAL : 136.11 (+1.12%)
MPC : 254.06 (+0.20%)
SNDK : 2,090.71 (-10.46%)
RKLB : 84.54 (+4.77%)
$IUXX : 29,118.24 (-1.09%)
ZNU26 : 110-085s (+0.16%)
OXY : 49.99 (-2.38%)
CRWV : 96.58 (-2.21%)
ALAB : 391.74 (-1.57%)
ESU26 : 7,401.75s (-0.29%)
AMD : 521.58 (-2.06%)
CTSH : 40.03 (+2.25%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J. , June 4, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform...

INSM : 103.38 (-1.04%)
Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference

BRIDGEWATER, N.J. , May 27, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform...

INSM : 103.38 (-1.04%)
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus

Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s...

INSM : 103.38 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

3rd Resistance Point 112.37
2nd Resistance Point 110.25
1st Resistance Point 106.82
Last Price 103.38
1st Support Level 101.27
2nd Support Level 99.15
3rd Support Level 95.72

See More

52-Week High 212.75
Fibonacci 61.8% 166.01
Fibonacci 50% 151.57
Fibonacci 38.2% 137.13
Last Price 103.38
52-Week Low 90.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.